Article - 22/10/2012 The crème de la crème of contact allergy tests goes in vitro As of 2013 all cosmetic products containing a chemical with inherent skin sensitisation potential must be tested without the traditional animal testing. Prof. Dr. Stefan Martin from the Department of Dermatology at the University of Freiburg Medical Centre and his partners have been looking for alternatives to animal testing and have come up with the most specific in vitro test there has ever been. The researchers involved in the project have…https://www.gesundheitsindustrie-bw.de/en/article/news/the-cr-me-de-la-cr-me-of-contact-allergy-tests-goes-in-vitro
Article - 22/10/2012 syneed imaging: precise visualisation of functional tissue properties Functional medical imaging modalities are of great significance in modern medical diagnostics. Existing ways of diagnosing diseases are now being expanded with the arrival of the innovative parameter imaging method. syneed imaging uses proprietary highly sensitive software for the analysis of dynamic image data. This software complements standard methods such as computed tomography and magnetic resonance imaging and increases the significance of…https://www.gesundheitsindustrie-bw.de/en/article/news/syneed-imaging-precise-visualisation-of-functional-tissue-properties
Press release - 22/10/2012 New Commission proposal to minimise the climate impacts of biofuel production On 17th October 2012, the Commission published a proposal to limit global land conversion for biofuel production, and raise the climate benefits of biofuels used in the EU. Through changes of the current legislation the Commission wants to promote biofuels that help achieving substantial emission cuts, do not directly compete with food and are more sustainable at the same time.https://www.biooekonomie-bw.de/en/articles/pm/new-commission-proposal-to-minimise-the-climate-impacts-of-biofuel-production
Press release - 16/10/2012 Merck Serono Launches € 1 Million Research Grant for Multiple Sclerosis Innovation Merck Serono, a division of Merck, Darmstadt, Germany, announced on 10th Oktober 2012 during the European Committee for Treatment and Research in Multiple Sclerosis (ECTRIMS) congress in Lyon, France, that the company has initiated a new global research award to improve understanding of multiple sclerosis for the ultimate benefit of patients.https://www.gesundheitsindustrie-bw.de/en/article/press-release/merck-serono-launches-1-million-research-grant-for-multiple-sclerosis-innovation
Article - 15/10/2012 Nobel Prize for the reprogramming of cells The Nobel Prize in Physiology or Medicine 2012 was awarded jointly to Sir John B. Gurdon and Shinya Yamanaka for the discovery that mature cells can be reprogrammed to become pluripotent, i.e. immature cells capable of developing into all tissues of the body. This finding is of revolutionary importance for the field of medicine.https://www.gesundheitsindustrie-bw.de/en/article/news/nobel-prize-for-the-reprogramming-of-cells
Article - 15/10/2012 Vegetables help fend off bacteria in the intestines Their discovery in the human intestines came as quite a surprise up until a few years ago LTi lymphoid tissue inducer - cells were only known to be involved in the embryonic development of the immune system. A team of researchers led by Prof. Dr. Andreas Diefenbach from the University of Freiburg Medical Centre has since been able to show the protective role played by LTi cells in fortifying the intestinal wall as a reaction to nutrients found…https://www.gesundheitsindustrie-bw.de/en/article/news/vegetables-help-fend-off-bacteria-in-the-intestines
Article - 15/10/2012 gerbion®: hunting down pathogens Detecting viruses, bacteria or parasites in human, animal, food and environmental samples is routine for the staff of gerbion GmbH & Co. KG. The company has been using virological, microbiological and serological methods for many years, but is now also using cutting-edge molecular biology methods for detecting pathogens. The founders of the Kornwestheim-based diagnostics company have concentrated on own research work and the development of…https://www.gesundheitsindustrie-bw.de/en/article/news/gerbion-hunting-down-pathogens
Article - 15/10/2012 Rudolf Hausmann – green surfactants from bacteria In April 2012 Rudolf Hausmann jr. was appointed professor of the newly established chair of bioprocess engineering at the University of Hohenheim. His passion biosurfactants used in cleaning agents detergents and foods which will in the future enable normally non-mixable liquids such as oil and water to be mixed together.https://www.biooekonomie-bw.de/en/articles/news/rudolf-hausmann-green-surfactants-from-bacteria
Article - 15/10/2012 Carmen Ruiz de Almodóvar and the link between the nervous and vascular systems Dr. Carmen Ruiz de Almodóvar from the Heidelberg University Biochemistry Centre has been awarded an ERC Starting Grant to study the molecular similarities between the nervous and vascular systems. The researcher showed that angiogenic factors such as VEGF also control the growth of neuronal cells and may be responsible for disorders in the development of nervous systems.https://www.gesundheitsindustrie-bw.de/en/article/news/carmen-ruiz-de-almod-var-and-the-link-between-the-nervous-and-vascular-systems
Article - 15/10/2012 ERC Starting Grants 2012: Baden-Württemberg achieves above-average success On September 10th 2012, the European Research Council (ERC) announced the results of the fifth funding round of its Starting Grants. Baden-Württemberg was awarded 13 grants, and is the state with the largest number of a total of 34 grants awarded to German life sciences researchers. Baden-Württemberg life sciences researchers will be receiving Starting Grants worth around 20 million euros.https://www.gesundheitsindustrie-bw.de/en/article/news/erc-starting-grants-2012-baden-wuerttemberg-achieves-above-average-success
Article - 15/10/2012 Rudolf Hausmann – green surfactants from bacteria In April 2012 Rudolf Hausmann jr. was appointed professor of the newly established chair of bioprocess engineering at the University of Hohenheim. His passion biosurfactants used in cleaning agents detergents and foods which will in the future enable normally non-mixable liquids such as oil and water to be mixed together.https://www.gesundheitsindustrie-bw.de/en/article/news/rudolf-hausmann-green-surfactants-from-bacteria
Article - 15/10/2012 gerbion®: hunting down pathogens Detecting viruses, bacteria or parasites in human, animal, food and environmental samples is routine for the staff of gerbion GmbH & Co. KG. The company has been using virological, microbiological and serological methods for many years, but is now also using cutting-edge molecular biology methods for detecting pathogens. The founders of the Kornwestheim-based diagnostics company have concentrated on own research work and the development of…https://www.biooekonomie-bw.de/en/articles/news/gerbion-hunting-down-pathogens
Press release - 11/10/2012 Novalung GmbH receives EU grant for the development of a cell-coated artificial lung The AmbuLung (Ambulatory Bioartificial Lung) project is a milestone in the history of artificial organs and is being subsidized by the EU with a total of 5.6 Million Euros - 3 Million Euros will go to Novalung as the Coordinator of the European development consortium. The joint developmental goal is the AmbuLung, which will allow patients to remain awake, mobile and active despite lung failure. The core innovation within the framework of the…https://www.gesundheitsindustrie-bw.de/en/article/press-release/novalung-gmbh-receives-eu-grant-for-the-development-of-a-cell-coated-artificial-lung
Press release - 09/10/2012 Bacterium in a Laser Trap Scientists from the Department of Microsystems Engineering IMTEK of the University of Freiburg have constructed an innovative new optical trap that can grab and scan tiny elongated bacteria with the help of a laser. Optical tweezers could previously only be used to grab bacteria at one point not to manipulate their orientation. The Freiburg researchers have now succeeded in using a quickly moving focused laser beam to exert an equally distributed…https://www.gesundheitsindustrie-bw.de/en/article/press-release/bacterium-in-a-laser-trap
Press release - 09/10/2012 VC-BW: new venture capital network established in Baden-Württemberg VC-BW a joint project run by the Baden-Württemberg Ministry of Finances and Economics and Stuttgart Financial is aimed at creating a common platform for existing business angel networks VC forums business development banks and VC companies. The overall goal of VC-BW is to make Baden-Württemberg more visible and attractive for investors from outside Baden-Württemberg. In addition it will give start-up companies easier access to higher investment…https://www.gesundheitsindustrie-bw.de/en/article/press-release/vc-bw-new-venture-capital-network-established-in-baden-wuerttemberg
Press release - 09/10/2012 VC-BW: new venture capital network established in Baden-Württemberg VC-BW a joint project run by the Baden-Württemberg Ministry of Finances and Economics and Stuttgart Financial is aimed at creating a common platform for existing business angel networks VC forums business development banks and VC companies. The overall goal of VC-BW is to make Baden-Württemberg more visible and attractive for investors from outside Baden-Württemberg. In addition it will give start-up companies easier access to higher investment…https://www.bio-pro.de/en/information/press-release/vc-bw-new-venture-capital-network-established-in-baden-wuerttemberg
Press release - 09/10/2012 European Commission proposes measures to tackle 'biopiracy' and facilitate nature-based research On 4th October 2012 researchers and companies in the EU received a boost today with a new proposal that should provide reliable access to genetic resources from outside the Union. The proposal is designed to protect the rights of countries and of indigenous and local communities that allow their genetic resources and associated traditional knowledge to be used while also giving researchers in Europe improved reliable access to quality samples of…https://www.gesundheitsindustrie-bw.de/en/article/press-release/european-commission-proposes-measures-to-tackle-biopiracy-and-facilitate-nature-based-research
Article - 08/10/2012 Epilepsy changes brain architecture Epileptic fits, i. e. abnormal excessive neuronal activity in the hippocampus, severely affects nerve cells and can lead to permanent damage. A team of researchers led by Prof. Dr. Carola Haas from the Neurocenter at the University of Freiburg is focusing on changes in the brain anatomy of patients suffering from temporal lobe epilepsy as well as on the molecular and cellular processes underlying the disease. The team’s research focuses on stem…https://www.gesundheitsindustrie-bw.de/en/article/news/epilepsy-changes-brain-architecture
Article - 08/10/2012 Martin Beck and the nuclear pore atlas Dr. Martin Beck from the European Molecular Biology Laboratory in Heidelberg was awarded an ERC Starting Grant for his project “Atlas of Cell-Type Specific Nuclear Pore Complex Structures”. The combination of cryo-electron microscope tomography, proteomics and biochemical methods will enable the creation of a high-resolution three-dimensional image of the nuclear pore complex.https://www.gesundheitsindustrie-bw.de/en/article/news/martin-beck-and-the-nuclear-pore-atlas
Dossier - 08/10/2012 Marine biotechnology: unknown sources of hope from the depths of the sea Biotechnological methods are used to investigate marine life and the results obtained from these investigations advance research in the fields of medicine and energy and into substances used as food supplements and cosmetics. The area of marine biotechnology is fairly diverse. Although it is not on the coast even the southern German state of Baden-Württemberg is involved in marine biotechnology.https://www.gesundheitsindustrie-bw.de/en/article/dossier/marine-biotechnology-unknown-sources-of-hope-from-the-depths-of-the-sea
Dossier - 08/10/2012 Marine biotechnology: unknown sources of hope from the depths of the sea Biotechnological methods are used to investigate marine life and the results obtained from these investigations advance research in the fields of medicine and energy and into substances used as food supplements and cosmetics. The area of marine biotechnology is fairly diverse. Although it is not on the coast even the southern German state of Baden-Württemberg is involved in marine biotechnology.https://www.biooekonomie-bw.de/en/articles/dossiers/marine-biotechnology-unknown-sources-of-hope-from-the-depths-of-the-sea
Article - 08/10/2012 A systems biology approach to understanding tumour growth Researchers at the Center Systems Biology in Stuttgart are developing multi-scale models of tumour growth with the aim of predicting how drugs spread and disperse in the tissue. The simulations can also take into account potential effects of pharmacological compounds and irradiation. The method will benefit researchers and clinicians by assisting them in their efforts to develop more efficient therapies. https://www.gesundheitsindustrie-bw.de/en/article/news/a-systems-biology-approach-to-understanding-tumour-growth
Article - 08/10/2012 The Heidelberg Institute of Human Genetics celebrates its 50th anniversary On the occasion of its 50th anniversary, the Institute of Human Genetics at the University Hospital of Heidelberg celebrates its major achievements in molecular genetic analyses, the diagnosis of hereditary diseases and tumour diseases as well as its research into the molecular causes of genetic defects. The largest institute of human genetics in Germany is also at the forefront of genetic counselling and debates on health policies and ethical…https://www.gesundheitsindustrie-bw.de/en/article/news/the-heidelberg-institute-of-human-genetics-celebrates-its-50th-anniversary
Press release - 08/10/2012 Affimed raises € 15.5 million in a Series D financing round Affimed Therapeutics AG the therapeutic TandAb antibody company announced the successful closing of a Series D financing round of 15.5 million on 8 October 2012. The proceeds from this transaction will be used to fund the clinical development of Affimeds therapeutic pipeline that consists of two TandAb products AFM11 and AFM13. Both candidates have unique properties as shown in preclinical studies.https://www.gesundheitsindustrie-bw.de/en/article/press-release/affimed-raises-15-5-million-in-a-series-d-financing-round
Guest article - 08/10/2012 Field report: research stay in Inner Mongolia Elke Scheibler spent three months in the Alashan desert working on a joint project of the University of Stuttgart and the Inner Mongolia Agricultural University in Hohhot. Elke Scheibler is a Margarete von Wrangell scholar at Stuttgart University and is currently working on her habilitation thesis on the plasticity of circadian rhythms under the influence of changing species communities. Here she reports on her stay abroad.https://www.gesundheitsindustrie-bw.de/en/article/news/field-report-research-stay-in-inner-mongolia